Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong

Journal of Infection

Volumn 54, Issue 1, 2007, Pages 28-39

  Yin Chun Yam, Loretta ^a   Chun Wing Lau, Arthur ^a   Yuk Lin Lai, Florence ^b   Shung, Edwina ^b   Chan, Jane ^b   Wong, Vivian ^b  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b NONE

Author keywords

Corticosteroids; Severe acute respiratory syndrome; Treatment

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; RIBAVIRIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM CULTURE; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; DRUG POTENCY; FEMALE; FUNGUS CULTURE; HONG KONG; HOSPITAL ADMISSION; HUMAN; IMMUNOPATHOLOGY; INDEPENDENT VARIABLE; INFECTION CONTROL; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RESPIRATORY FUNCTION; RISK ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; FEMALE; HONG KONG; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME;

EID: 33845598393     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.01.005     Document Type: Article

References (33)

1. Zhong N.S., and Zeng G.Q. Our strategies for fighting severe acute respiratory syndrome (SARS). Am J Respir Crit Care Med 168 (2003) 7-9
2. Choi K.W., Chau T.N., Tsang O., Tso E., Chiu M.C., Tong W.L., et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 139 (2003) 715-723
3. So L.K.Y., Lau A.C.W., Yam L.Y.C., Cheung T.M., Poon E., Yung R.W., et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 361 (2003) 1615-1617
4. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348 (2003) 1986-1994
5. Ho J.C., Ooi G.C., Mok T.Y., Chan J.W., Hung I., Lam B., et al. High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 168 (2003) 1449-1456
6. Peiris J.S.M., Chu C.M., Cheng V.C., Chan K.S., Hung I.F., Poon L.L., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 (2003) 1767-1772
7. Lau A.C., and So L.K. Severe acute respiratory syndrome treatment: present status and future strategy. Curr Opin Investig Drugs 4 (2003) 918-920
8. Wong C.K., Lam C.W., Wu A.K., Ip W.K., Lee N.L., Chan I.H., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136 (2004) 95-103
9. Wong R.S., and Hui D.S. Index patient and SARS outbreak in Hong Kong. Emerg Infect Dis 10 (2004) 339-341
10. Hsu L.Y., Lee C.C., Green J.A., Ang B., Paton N.I., Lee L., et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 9 (2003) 713-717
11. Li X.W., Jiang R.M., and Guo J.Z. Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report. Chin J Intern Med 42 (2003) 378-381
12. Wang H., Ding Y., Li X., Yang L., Zhang W., Kang W., et al. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med 349 (2003) 507-508
13. World Health Organisation. Case definitions for surveillance of severe acute respiratory syndrome (SARS). revised May 1 (2003). http://www.who.int/csr/sars/casedefinition [accessed July 8, 2004]
14. Severinghaus J.W., Stafford M., and Thunstrom A.M. Estimation of skin metabolism and blood flow with tcPO2 and tcPO2 electrodes by cuff occlusion of the circulation. Acta Anaesthesiol Scand Suppl 68 (1978) 9-15
15. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 3 Pt 1 (1994) 818-824
16. Fowler R.A., Lapinsky S.E., Hallet D., Detsky A.S., Sibbald W.J., Slutsky A.S., et al. Critically ill patients with severe acute respiratory distress syndrome. JAMA 290 (2003) 363-373
17. Lew T.W., Kwek T.K., Tai D., Earnest A., Loo S., Singh K., et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory distress syndrome. JAMA 290 (2003) 374-380
18. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W., et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (2003) 2045-2046
19. Chen F., Chan K.H., Jiang Y., Kao R.Y., Lu H.T., Fan K.W., et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compound. J Clin Virol 31 (2004) 69-75
20. Morgenstern B., Michaelis M., Baer P.C., Doerr H.W., and Cinatl Jr. J. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochem Biophys Res Commun 326 (2005) 905-908
21. Jiang Y., Xu J., Zhou C., Wu Z., Zhong S., Liu J., et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 17 (2005) 850-857
22. Beijing Group of National Research Project of SARS. Dynamic changes in blood cytokine levels as clinical indicators in severe actue respiratory syndrome. Chin Med J (Engl) 116 (2003) 1283-1287
23. Chan K.S., Lai S.T., Chu C.M., Tsui E., Tam C.Y., Wong M.M., et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 9 6 (December 2003) 399-406
24. Langhoff E., Ladefoged J., and Dickmeiss E. The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cells. Int J Immunopharmacol 7 (1985) 483-489
25. Langhoff E., and Ladefoged J. Relative immunosuppressive potency of various corticosteroids measured in vitro. Eur J Clin Pharmacol 25 (1983) 459-462
26. Sung J.J., Wu A., Joynt G.M., Yuen K.Y., Lee N., Chan P.K., et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 59 (2004) 414-420
27. Chan J.W., Ng C.K., Chan Y.H., Mok T.Y., Lee S., Chu S.Y., et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 58 (2003) 686-689
28. Lau A.C., So L.K., Miu F.P., Yung R.W., Poon E., Cheung T.M., et al. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology 9 (2004) 173-183
29. Zhao Z., Zhang F., Xu M., Huang K., Zhong W., Cai W., et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 52 Pt 8 (2003) 715-720
30. Tsui P.T., Kwok M.L., Yuen H., Lai S.T., et al. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 9 (2003) 1064-1069
31. Tsang O.T., Chau T.N., Choi K.W., Tso E.Y., Lim W., Chiu M.C., et al. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis 9 (2003) 1381-1387
32. Lee N., Allen Chan K.C., Hui D.S., Ng E.K., Wu A., Chiu R.W., et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentration in adult patients. J Clin Virol 31 (2004) 304-309
33. Meduri G.U., Kanangat S., Stefan J., Tolley E., Schaberg D., et al. Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med 160 (1999) 961-967